Optimer Pharmaceuticals, Inc. was founded and registered as a Delaware Corporation in 1998. The Company headquarters and R&D laboratory are located in San Diego, California, and recently opened their commercial headquarters in Jersey City, New Jersey. Optimer has one subsidiary, Optimer Biotechnology, Inc. located in Taipei, Taiwan. We have over 240 employees worldwide. Optimer is focused on discovering, developing, and commercializing innovative hospital specialty products that have a positive impact on society. The Company’s focus is on medicines that make a significant difference in the lives of patients and reduce the burden of disease. On May 27, 2011, the FDA approved Optimer's DIFICID™ (fidaxomicin) tablets for the treatment of patients with Clostridium difficile-Associated Diarrhea (CDAD). DIFICID is the first antibacterial drug indicated for CDAD to be approved in nearly 30 years. It is indicated for the treatment of CDAD in adults 18 years of age or older. DIFICID is administered in 200 mg tablets given orally twice daily.

The Company offers a comprehensive benefits package and career growth opportunities.

• Medical, Dental, and Vision Insurance Programs
• Life and AD&D Insurance
• Short Term and Long Term Disability
• Flexible Spending Accounts
• Employee Assistance Program
• Employee Stock Purchase Plan
• Additional Voluntary Benefits
• Paid vacation and sick leave programs
• Holidays – 11 paid holidays per year
• Educational Assistance Program
• 401(k) Savings Plan
• Stock Option Plan